Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017632HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017881HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018525HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017751HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017576HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017599HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10007402HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10007403HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018891HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018526HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807